Senior insider sale
UNITED THERAPEUTICS CORP — senior position signals high conviction
$80.3K
374.00 shares
What this filing means
MESA NILDA plans to sell 374.00 shares of UNITED THERAPEUTICS CORP valued at approximately $80.3K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 5/5/2023ACC: 0001950047-23-000440
374.00
Shares to sell
$80.3K
Approx. market value
374.00
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months2
Restricted Stock
None
6/26/2021
140.00Restricted Stock
None
6/26/2020
234.00Total acquired374.00
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/26/2021 | Restricted Stock None | 140.00 | — |
6/26/2020 | Restricted Stock None | 234.00 | — |
| Total | 374.00 | ||
Planned & Completed Dispositions1
NASDPlanned
Units to sell
374.00
Market value
$80.3K
5/5/2023
Total
Units
374.00
Value
$80.3K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
5/5/2023 | 374.00 | $80.3K | NASD | Planned |
| Total | 374.00 | $80.3K | ||